About
Susan E. Graf has served on Aardvark's Board since November 2024. Since May 2021 she has been a Senior Advisor and Entrepreneur in Residence at Locust Walk Partners, LLC. She was Chief Executive Officer of Akamara Therapeutics from 2019 to 2021 and Chief Business Officer (and Principal Financial Officer) of Epizyme, Inc. from 2016 to 2018, and earlier held roles at NPS Pharma and spent nearly 18 years at Roche. Ms. Graf received her M.B.A. from the Stern School of Business at New York University and her B.Pharm. from Purdue University. She serves on Aardvark's Compensation and Audit Committees.
Roles
Aardvark Therapeutics, Inc.
Director · Current role
November 2024–present
Locust Walk Partners, LLC
Senior Advisor & Entrepreneur in Residence
2021 - present
Akamara Therapeutics, Inc.
Chief Executive Officer
2019 - 2021
Epizyme, Inc.
Chief Business Officer (and Principal Financial Officer)
2016 - 2018
NPS Pharma
Vice President, Corporate Development and Strategy
—
Roche
Various leadership and executive positions · ~18 years
—
External Roles
CG Oncology, Inc.
Director & Audit Committee Chair
2021 - present
Finch Therapeutics, Inc.
Chair of the Board & Audit Committee
2021 - 2024
Director Compensation
FY 2025
Fees earned or paid in cash
$61,562
Also at Aardvark Therapeutics, Inc.